Grant: Doctoral Award - Doctoral Foreign Study Award (DFSA)
Direct Payment
$105,000.00
Dynein/dynactin mutations associated with amyotrophic lateral sclerosis and their effect on axonal transport and neuromuscular junction formation in the zebrafish embryo.
EF 2013-14
Résumé
Amyotrophic lateral sclerosis (ALS) is an adult-onset fatal neurodegenerative disease, causing motor neuron degeneration, neuromuscular junction disruption, and muscle atrophy, which is mainly sporadic in nature. Mutations in the gene DCTN1, coding for the motor protein complex component dynactin, have been identified in some ALS patients, and reports have found reduced levels of dynactin in sporadic ALS patients. Neurons are highly polarized cells that depend on active axonal transport for growth, establishment and maintenance of synapses. Motor neurons present a challenge in this regard, as they need to extend very long axons in order to reach their target muscle cells and establish the neuromuscular junction. It is therefore not surprising that axonal transport deficits have been observed in various neurodegenerative diseases.
Defects in transport of material for development or clearance of detritus in the axon can lead to neuronal stress and cell death. Considering the dynamics of axonal transport, defects could arise from different causes: preferential type of transport, varying load size (possibly due to protein aggregation) or severity of depletion or dilution of the motor protein populations. Independently from the motor dynamics defects, there could be other impairments depending on cargo adapter proteins or chemical mediators, like phosphorylation. In order to determine how axonal transport is involved in the pathogenesis of ALS, we propose to investigate the changes occurring in fast axonal transport upon the expression of an ALS-related mutant form of dynactin in the zebrafish embryo.
This project aims at understanding how mutations in molecular motors affect motor neuron and NMJ formation, function, and stability, and in what way axonal transport is impaired. We hope to elucidate the role of the mutant dynein/dynactin complex in motor neuron degeneration associated with ALS.
Programme
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Bénéficiaire
Emplacement
France
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
307706
Name
Bercier Valérie
Country
France
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Dynein/dynactin mutations associated with amyotrophic lateral sclerosis and their effect on axonal transport and neuromuscular junction formation in the zebrafish embryo.
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Keyworddelim
Aging; Amyotrophic Lateral Sclerosis; Axonal Transport; Dynactin; Dynein; In-Vivo Live Imaging; Neurodegeneration; Neuromuscular Junction; P150; Zebrafish
Abstract
Amyotrophic lateral sclerosis (ALS) is an adult-onset fatal neurodegenerative disease, causing motor neuron degeneration, neuromuscular junction disruption, and muscle atrophy, which is mainly sporadic in nature. Mutations in the gene DCTN1, coding for the motor protein complex component dynactin, have been identified in some ALS patients, and reports have found reduced levels of dynactin in sporadic ALS patients. Neurons are highly polarized cells that depend on active axonal transport for growth, establishment and maintenance of synapses. Motor neurons present a challenge in this regard, as they need to extend very long axons in order to reach their target muscle cells and establish the neuromuscular junction. It is therefore not surprising that axonal transport deficits have been observed in various neurodegenerative diseases.
Defects in transport of material for development or clearance of detritus in the axon can lead to neuronal stress and cell death. Considering the dynamics of axonal transport, defects could arise from different causes: preferential type of transport, varying load size (possibly due to protein aggregation) or severity of depletion or dilution of the motor protein populations. Independently from the motor dynamics defects, there could be other impairments depending on cargo adapter proteins or chemical mediators, like phosphorylation. In order to determine how axonal transport is involved in the pathogenesis of ALS, we propose to investigate the changes occurring in fast axonal transport upon the expression of an ALS-related mutant form of dynactin in the zebrafish embryo.
This project aims at understanding how mutations in molecular motors affect motor neuron and NMJ formation, function, and stability, and in what way axonal transport is impaired. We hope to elucidate the role of the mutant dynein/dynactin complex in motor neuron degeneration associated with ALS.
Competitiondate
201310
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bercier, Valérie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~